Your browser doesn't support javascript.
loading
T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis.
Briukhovetska, Daria; Suarez-Gosalvez, Javier; Voigt, Cornelia; Markota, Anamarija; Giannou, Anastasios D; Schübel, Maryam; Jobst, Jakob; Zhang, Tao; Dörr, Janina; Märkl, Florian; Majed, Lina; Müller, Philipp Jie; May, Peter; Gottschlich, Adrian; Tokarew, Nicholas; Lücke, Jöran; Oner, Arman; Schwerdtfeger, Melanie; Andreu-Sanz, David; Grünmeier, Ruth; Seifert, Matthias; Michaelides, Stefanos; Hristov, Michael; König, Lars M; Cadilha, Bruno Loureiro; Mikhaylov, Oleg; Anders, Hans-Joachim; Rothenfusser, Simon; Flavell, Richard A; Cerezo-Wallis, Daniela; Tejedo, Cristina; Soengas, María S; Bald, Tobias; Huber, Samuel; Endres, Stefan; Kobold, Sebastian.
Afiliación
  • Briukhovetska D; Division of Clinical Pharmacology, Klinikum der Universität München, 80337 Munich, Germany.
  • Suarez-Gosalvez J; Division of Clinical Pharmacology, Klinikum der Universität München, 80337 Munich, Germany.
  • Voigt C; Division of Clinical Pharmacology, Klinikum der Universität München, 80337 Munich, Germany.
  • Markota A; Division of Clinical Pharmacology, Klinikum der Universität München, 80337 Munich, Germany.
  • Giannou AD; Section of Molecular Immunology and Gastroenterology, I. Department of Medicine, and Hamburg Center for Translational Immunology (HCTI), University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppend
  • Schübel M; Division of Clinical Pharmacology, Klinikum der Universität München, 80337 Munich, Germany.
  • Jobst J; Division of Clinical Pharmacology, Klinikum der Universität München, 80337 Munich, Germany.
  • Zhang T; Section of Molecular Immunology and Gastroenterology, I. Department of Medicine, and Hamburg Center for Translational Immunology (HCTI), University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Dörr J; Division of Clinical Pharmacology, Klinikum der Universität München, 80337 Munich, Germany.
  • Märkl F; Division of Clinical Pharmacology, Klinikum der Universität München, 80337 Munich, Germany.
  • Majed L; Division of Clinical Pharmacology, Klinikum der Universität München, 80337 Munich, Germany.
  • Müller PJ; Division of Clinical Pharmacology, Klinikum der Universität München, 80337 Munich, Germany.
  • May P; Division of Clinical Pharmacology, Klinikum der Universität München, 80337 Munich, Germany.
  • Gottschlich A; Division of Clinical Pharmacology, Klinikum der Universität München, 80337 Munich, Germany.
  • Tokarew N; Division of Clinical Pharmacology, Klinikum der Universität München, 80337 Munich, Germany.
  • Lücke J; Section of Molecular Immunology and Gastroenterology, I. Department of Medicine, and Hamburg Center for Translational Immunology (HCTI), University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppend
  • Oner A; Division of Clinical Pharmacology, Klinikum der Universität München, 80337 Munich, Germany.
  • Schwerdtfeger M; Division of Clinical Pharmacology, Klinikum der Universität München, 80337 Munich, Germany.
  • Andreu-Sanz D; Division of Clinical Pharmacology, Klinikum der Universität München, 80337 Munich, Germany.
  • Grünmeier R; Division of Clinical Pharmacology, Klinikum der Universität München, 80337 Munich, Germany.
  • Seifert M; Division of Clinical Pharmacology, Klinikum der Universität München, 80337 Munich, Germany.
  • Michaelides S; Division of Clinical Pharmacology, Klinikum der Universität München, 80337 Munich, Germany.
  • Hristov M; Institute for Cardiovascular Prevention (IPEK), University Hospital, Klinikum der Universität München, Munich, Germany.
  • König LM; Division of Clinical Pharmacology, Klinikum der Universität München, 80337 Munich, Germany.
  • Cadilha BL; Division of Clinical Pharmacology, Klinikum der Universität München, 80337 Munich, Germany.
  • Mikhaylov O; TwentyBN, 10245 Berlin, Germany.
  • Anders HJ; Division of Nephrology, Department of Medicine IV, Klinikum der Universität München, 80337 Munich, Germany.
  • Rothenfusser S; Division of Clinical Pharmacology, Klinikum der Universität München, 80337 Munich, Germany; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), 85764 Neuherberg, Germany.
  • Flavell RA; Department of Immunobiology, School of Medicine, Yale University, New Haven, CT 06520, USA; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06520, USA.
  • Cerezo-Wallis D; Melanoma Laboratory, Molecular Oncology Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.
  • Tejedo C; Melanoma Laboratory, Molecular Oncology Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.
  • Soengas MS; Melanoma Laboratory, Molecular Oncology Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.
  • Bald T; Institute of Experimental Oncology, Medical Faculty, University Hospital Bonn, University of Bonn, 53127 Bonn, Germany.
  • Huber S; Section of Molecular Immunology and Gastroenterology, I. Department of Medicine, and Hamburg Center for Translational Immunology (HCTI), University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Endres S; Division of Clinical Pharmacology, Klinikum der Universität München, 80337 Munich, Germany; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), 85764 Neuherberg, Germany; Center for Translational Cancer Research (DKTK), Part
  • Kobold S; Division of Clinical Pharmacology, Klinikum der Universität München, 80337 Munich, Germany; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), 85764 Neuherberg, Germany; Center for Translational Cancer Research (DKTK), Part
Immunity ; 56(1): 143-161.e11, 2023 01 10.
Article en En | MEDLINE | ID: mdl-36630913
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptores Virales / Interleucinas / Linfocitos T Colaboradores-Inductores / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Immunity Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptores Virales / Interleucinas / Linfocitos T Colaboradores-Inductores / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Immunity Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Alemania